Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18929399 | Aortic ARCH Baroreceptor Implants for Treatment of Hypertension | October 2024 | October 2025 | Allow | 12 | 1 | 1 | Yes | No |
| 18920818 | TAPERED JUGULAR STENTS FOR VASCULAR INTERVENTIONS, AND SYSTEMS AND DEVICES THEREOF | October 2024 | June 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 18853671 | LEFT VENTRICULAR OUTFLOW TRACT STENT AND DELIVERY SYSTEM | October 2024 | March 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 18783153 | Growth Stent and Valve for Congenital Narrowings | July 2024 | May 2025 | Abandon | 10 | 1 | 0 | No | No |
| 18768710 | PROSTHETIC HEART VALVES | July 2024 | January 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 18639404 | STENT | April 2024 | May 2025 | Allow | 13 | 1 | 0 | No | No |
| 18630501 | PROSTHETIC VALVES WITH MECHANICALLY COUPLED LEAFLETS | April 2024 | January 2026 | Allow | 22 | 2 | 0 | Yes | No |
| 18618560 | GEOMETRICALLY-ACCOMMODATING HEART VALVE REPLACEMENT DEVICE | March 2024 | February 2026 | Allow | 23 | 2 | 0 | Yes | No |
| 18593136 | PROSTHETIC VALVE DEVICE RESISTANT TO BACKFOLDING AND BUCKLING | March 2024 | March 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18587076 | SYSTEM, DEVICES AND METHODS FOR ANCHORING AND/OR SEALING A HEART VALVE PROSTHESIS | February 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18431963 | MODULAR AORTIC STENT-GRAFT WITH BRANCH EXTENSIONS AND ENDOVASCULAR METHOD OF REPAIRING AN AORTIC ANEURYSM WITH A MODULAR STENT-GRAFT | February 2024 | August 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18428630 | PROSTHETIC HEART VALVES | January 2024 | May 2024 | Allow | 3 | 1 | 0 | No | No |
| 18424717 | PULMONARY ARTERY STENT | January 2024 | April 2025 | Allow | 15 | 1 | 0 | Yes | No |
| 18414437 | SYSTEMS AND METHODS FOR MAGNETIC JOINTS | January 2024 | November 2025 | Allow | 22 | 3 | 0 | Yes | No |
| 18413941 | REPLACEMENT HEART VALVE AND METHOD | January 2024 | January 2026 | Allow | 24 | 3 | 0 | Yes | No |
| 18411496 | Passive Alignment of Commissures in Prosthetic Heart Valve Implantation | January 2024 | October 2025 | Allow | 22 | 1 | 1 | Yes | No |
| 18402217 | STENT | January 2024 | September 2024 | Allow | 9 | 1 | 0 | No | No |
| 18395000 | REPOSITIONABLE AND REMOVABLE STENTS | December 2023 | February 2025 | Allow | 14 | 1 | 0 | No | No |
| 18501842 | GROWTH STENT AND VALVE FOR CONGENITAL NARROWINGS | November 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18495912 | ELLIPTICAL HEART VALVE PROSTHESES, DELIVERY SYSTEMS, AND METHODS OF USE | October 2023 | March 2025 | Allow | 16 | 2 | 0 | Yes | No |
| 18380413 | STENT GRAFT ASSEMBLY | October 2023 | March 2026 | Allow | 29 | 0 | 0 | Yes | No |
| 18465137 | APPARATUS AND METHODS FOR IMPLANTING A REPLACEMENT HEART VALVE | September 2023 | February 2025 | Allow | 17 | 2 | 0 | Yes | No |
| 18237603 | Self-Expanding Vascular Flow Reducer with Stabilized Throat Section | August 2023 | April 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18450284 | DEVICES AND METHODS FOR CORONARY SINUS PRESSURE RELIEF | August 2023 | January 2026 | Allow | 29 | 3 | 0 | Yes | No |
| 18232900 | ORIENTABLE IMPLANTABLE DEVICE AND METHOD | August 2023 | February 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18448494 | STEMLESS PROSTHESIS ANCHOR COMPONENT | August 2023 | June 2024 | Allow | 10 | 1 | 0 | No | No |
| 18351785 | GEOMETRICALLY-ACCOMMODATING HEART VALVE REPLACEMENT DEVICE | July 2023 | December 2023 | Allow | 5 | 1 | 0 | No | No |
| 18215223 | ORIENTABLE INTRACRANIAL OCCLUSION DEVICE AND METHOD | June 2023 | May 2025 | Allow | 22 | 1 | 0 | Yes | No |
| 18325637 | SYSTEMS TO AFFIX DEVICES TO INTRAOCULAR LENS ASSEMBLIES AND RELATED METHODS | May 2023 | August 2025 | Allow | 27 | 1 | 0 | No | No |
| 18135536 | PROSTHETIC HEART VALVES | April 2023 | November 2023 | Allow | 7 | 2 | 0 | Yes | No |
| 18135034 | DELIVERY SYSTEMS FOR STENTS HAVING PROTRUDING FEATURES | April 2023 | February 2025 | Allow | 22 | 1 | 0 | Yes | No |
| 18299182 | PULMONARY ARTERY STENT | April 2023 | November 2023 | Allow | 7 | 1 | 1 | Yes | No |
| 18024011 | DELIVERY SYSTEMS AND METHODS FOR PROSTHETIC HEART VALVE | February 2023 | December 2025 | Allow | 34 | 3 | 0 | Yes | No |
| 18114745 | AORTIC LANDING BAND SUPPORT METHOD AND SYSTEM | February 2023 | June 2025 | Allow | 27 | 3 | 0 | Yes | No |
| 18112513 | Tissue Gripper and Valve Clamping Device | February 2023 | February 2026 | Allow | 35 | 1 | 0 | Yes | No |
| 18112560 | FLEXIBLE PATULOUS EUSTACHIAN TUBE IMPLANT WITH INTEGRATED VENTING | February 2023 | November 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 18111164 | STENT WITH SHAPED WIRES | February 2023 | September 2024 | Allow | 19 | 1 | 1 | Yes | No |
| 18166797 | PROSTHETIC HEART VALVE DOCKING ASSEMBLY | February 2023 | July 2025 | Allow | 29 | 3 | 0 | Yes | No |
| 18040216 | BALLOON EXPANDABLE STENT WITH SYMMETRICAL CRIMPED CONFIGURATION FOR TRANSCATHETER IMPLANTATION OF A CARDIAC VALVE PROSTHESIS | February 2023 | December 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 18158445 | STENTS WITH INCREASED FLEXIBILITY | January 2023 | October 2024 | Allow | 21 | 2 | 0 | Yes | No |
| 18154100 | PROSTHESIS WITH ANTI-PARAVALVULAR LEAKAGE COMPONENT INCLUDING A ONE-WAY VALVE | January 2023 | May 2024 | Allow | 16 | 1 | 0 | Yes | No |
| 18069082 | MINIMALLY-INVASIVE LOW STRAIN ANNULOPLASTY RING | December 2022 | August 2024 | Allow | 19 | 2 | 0 | Yes | No |
| 18067821 | THORACIC AORTA STENT GRAFT | December 2022 | June 2025 | Allow | 30 | 1 | 0 | No | No |
| 17993573 | PROSTHETIC HEART VALVES | November 2022 | March 2023 | Allow | 4 | 1 | 0 | Yes | No |
| 18056633 | CARDIAC VALVE REPAIR SYSTEM AND METHODS OF USE | November 2022 | November 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17989621 | Growth Stent and Valve for Congenital Narrowings | November 2022 | August 2023 | Allow | 8 | 1 | 0 | No | No |
| 17983869 | GUIDE CATHETER FOR FLOW MODIFYING DEVICE | November 2022 | November 2024 | Allow | 24 | 1 | 1 | Yes | No |
| 18048393 | PROSTHETIC HEART VALVE | October 2022 | March 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 17965419 | SYSTEMS, DEVICES, AND METHODS FOR COUPLING A PROSTHETIC IMPLANT TO A FENESTRATED BODY | October 2022 | July 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 17963764 | STENT | October 2022 | January 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 17959850 | SHOULDER ARTHROPLASTY SYSTEMS AND CONFIGURATIONS FOR COMPONENTS THEREOF | October 2022 | April 2024 | Allow | 18 | 1 | 0 | No | No |
| 17953623 | ABSORBABLE INTRAVASCULAR DEVICES THAT SHORTEN UPON EXPANSION CREATING SPACE FOR VASCULAR MOVEMENT | September 2022 | April 2025 | Allow | 30 | 2 | 0 | No | No |
| 17949798 | OSTIAL STENTING UNDER VISION | September 2022 | October 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17947060 | SYSTEMS TO AFFIX DEVICES TO INTRAOCULAR LENS ASSEMBLIES AND RELATED METHODS | September 2022 | February 2023 | Allow | 5 | 0 | 0 | Yes | No |
| 17871834 | RETENTION DEVICES, LATTICES AND RELATED SYSTEMS AND METHODS | July 2022 | January 2024 | Abandon | 18 | 1 | 0 | No | No |
| 17866936 | REPOSITIONABLE AND REMOVABLE STENTS | July 2022 | September 2023 | Allow | 14 | 0 | 0 | Yes | No |
| 17865712 | MITRAL VALVE SPACER DEVICE | July 2022 | October 2024 | Allow | 27 | 2 | 0 | Yes | No |
| 17861155 | GRAFT WITH EXPANDABLE REGION AND METHODS OF MAKING AND USING THE SAME | July 2022 | August 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17748623 | MEDICAL IMPLANTS WITH STRUCTURAL MEMBERS HAVING BARBS FOR RETAINING RADIOPAQUE MARKERS | May 2022 | November 2023 | Allow | 18 | 1 | 0 | Yes | No |
| 17747507 | PROSTHETIC HEART VALVES | May 2022 | October 2022 | Allow | 5 | 1 | 0 | No | No |
| 17775346 | STENT DELIVERY ASSEMBLY | May 2022 | February 2026 | Allow | 45 | 2 | 0 | No | No |
| 17659212 | BRANCH STENT FOR IMPLANTATION FROM A MAIN BLOOD VESSEL AND DEPLOYMENT METHODS | April 2022 | October 2022 | Allow | 6 | 2 | 0 | Yes | No |
| 17715005 | BALLOON EXPANDED POLYMER STENT | April 2022 | February 2026 | Allow | 46 | 1 | 0 | Yes | No |
| 17689572 | IMPLANT WITH ARTICULATING SECTIONS | March 2022 | August 2024 | Allow | 29 | 2 | 0 | Yes | No |
| 17674671 | GROWTH STENT AND VALVE FOR CONGENITAL NARROWINGS | February 2022 | September 2022 | Allow | 7 | 1 | 0 | No | No |
| 17666086 | PROXIMAL TAB FOR SIDE-DELIVERED TRANSCATHETER HEART VALVES AND METHODS OF DELIVERY | February 2022 | February 2024 | Allow | 24 | 1 | 0 | Yes | No |
| 17590114 | PROSTHETIC VALVE DEVICE RESISTANT TO BACKFOLDING AND BUCKLING | February 2022 | December 2023 | Allow | 23 | 1 | 0 | Yes | No |
| 17575595 | STENTS WITH INCREASED FLEXIBILITY | January 2022 | November 2023 | Abandon | 22 | 1 | 0 | No | No |
| 17626511 | CONTINUOUS FIBER-REINFORCED BUILD MATERIAL FOR ADDITIVE MANUFACTURING | January 2022 | October 2025 | Allow | 45 | 1 | 0 | Yes | No |
| 17528696 | STENT DESIGNS TO COVER CATHETER ACCESS SITE | November 2021 | October 2025 | Abandon | 47 | 4 | 1 | No | No |
| 17611668 | AORTIC PRESSURE LOSS REDUCTION APPARATUS AND METHODS | November 2021 | October 2025 | Allow | 47 | 1 | 0 | Yes | No |
| 17609753 | ADJUSTABLE OPTICAL SYSTEM FOR INTRAOCULAR MICRO-DISPLAY | November 2021 | July 2025 | Allow | 45 | 1 | 0 | No | No |
| 17515756 | ORIENTABLE IMPLANTABLE DEVICE AND METHOD | November 2021 | February 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17509178 | DEVICES AND METHODS FOR PROTECTING AGAINST NEUROMAS | October 2021 | December 2024 | Allow | 38 | 0 | 0 | Yes | No |
| 17450171 | Passive Alignment of Commissures in Prosthetic Heart Valve Implantation | October 2021 | December 2023 | Allow | 26 | 1 | 1 | Yes | No |
| 17449253 | DEPLOYMENT OF MULTIPLE BILIARY STENTS | September 2021 | December 2025 | Allow | 51 | 1 | 1 | No | No |
| 17478665 | SERIALLY EXPANDING AN ARTIFICIAL HEART VALVE WITHIN A PEDIATRIC PATIENT | September 2021 | May 2022 | Allow | 8 | 1 | 0 | Yes | No |
| 17478713 | RING CONTRACTION DEVICE AND MOUNTING METHOD THEREOF | September 2021 | May 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17476867 | JACKET FOR SURGICAL HEART VALVE | September 2021 | January 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17475527 | MEDICAL IMPLANTS WITH STRUCTURAL MEMBERS HAVING BARBS FOR RETAINING RADIOPAQUE MARKERS | September 2021 | April 2022 | Allow | 7 | 1 | 0 | Yes | No |
| 17412428 | STENT | August 2021 | September 2023 | Allow | 25 | 1 | 1 | Yes | No |
| 17407250 | STEMLESS PROSTHESIS ANCHOR COMPONENT | August 2021 | May 2023 | Allow | 21 | 0 | 0 | Yes | No |
| 17408356 | DEVICES AND METHODS FOR MULTI-ALIGNMENT OF IMPLANTABLE MEDICAL DEVICES | August 2021 | September 2025 | Allow | 49 | 5 | 0 | No | Yes |
| 17402513 | BIORESORBABLE ENDOLUMINAL PROSTHESIS FOR MEDIUM AND LARGE VESSELS | August 2021 | April 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17400214 | Debranching Visceral Stent Grant and Methods for Use | August 2021 | March 2024 | Allow | 31 | 2 | 0 | Yes | No |
| 17443695 | MALE INCONTINENCE CONTROL DEVICE AND METHOD OF CONTROLLING MALE INCONTINENCE | July 2021 | August 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17425714 | PROSTHETIC FOOT COMPONENT | July 2021 | August 2025 | Allow | 49 | 5 | 0 | Yes | No |
| 17376242 | STABILIZED TOTAL ANKLE PROSTHESIS | July 2021 | January 2024 | Abandon | 30 | 2 | 0 | No | No |
| 17377091 | PROSTHETIC VALVES WITH MECHANICALLY COUPLED LEAFLETS | July 2021 | January 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17421930 | ENDOVASCULAR STENT GRAFT | July 2021 | June 2024 | Allow | 35 | 1 | 0 | Yes | No |
| 17354629 | LANDING ZONE FOR ENDOVASCULAR PROCEDURES | June 2021 | November 2022 | Allow | 17 | 1 | 0 | Yes | No |
| 17341038 | LAYERED MEDICAL APPLIANCES AND METHODS | June 2021 | June 2025 | Allow | 49 | 2 | 0 | Yes | No |
| 17338372 | CRAFTING OF CARTILAGE | June 2021 | September 2025 | Abandon | 52 | 2 | 0 | No | No |
| 17297229 | Coated Stent | May 2021 | September 2023 | Allow | 28 | 2 | 0 | Yes | No |
| 17321300 | RETRIEVAL DEVICES FOR HEART VALVE SEALING DEVICES | May 2021 | November 2024 | Allow | 42 | 2 | 1 | Yes | No |
| 17246853 | ORIENTABLE INTRACRANIAL OCCLUSION DEVICE AND METHOD | May 2021 | March 2023 | Allow | 23 | 0 | 0 | Yes | No |
| 17240599 | DEVICES AND METHODS FOR TREATING AN ANEURYSM | April 2021 | November 2025 | Allow | 55 | 1 | 0 | Yes | No |
| 17233159 | TRANSCATHETER DEVICE FOR ENDOVASCULAR AORTIC REPAIR AND METHOD OF USING THE SAME | April 2021 | August 2025 | Allow | 52 | 3 | 0 | No | No |
| 17230189 | Debranching Visceral Stent Grant and Methods for Use | April 2021 | January 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17230179 | Debranching Visceral Stent Grant and Methods for Use | April 2021 | September 2024 | Allow | 41 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PRESTON, REBECCA STRASZHEIM.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner PRESTON, REBECCA STRASZHEIM works in Art Unit 3774 and has examined 239 patent applications in our dataset. With an allowance rate of 87.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.
Examiner PRESTON, REBECCA STRASZHEIM's allowance rate of 87.9% places them in the 68% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by PRESTON, REBECCA STRASZHEIM receive 1.74 office actions before reaching final disposition. This places the examiner in the 37% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by PRESTON, REBECCA STRASZHEIM is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +45.3% benefit to allowance rate for applications examined by PRESTON, REBECCA STRASZHEIM. This interview benefit is in the 91% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 38.1% of applications are subsequently allowed. This success rate is in the 87% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 51.4% of cases where such amendments are filed. This entry rate is in the 77% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 43.8% are granted (fully or in part). This grant rate is in the 36% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 2.5% of allowed cases (in the 77% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.0% of allowed cases (in the 60% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.